219 related articles for article (PubMed ID: 1827941)
1. Myocardial perfusion imaging with technetium-99m-labeled agents.
Maddahi J; Kiat H; Berman DS
Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
[TBL] [Abstract][Full Text] [Related]
2. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
Berman DS; Kiat H; Maddahi J
Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
[TBL] [Abstract][Full Text] [Related]
3. Technetium-labeled myocardial perfusion agents.
Heo J; Iskandrian AS
Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
[TBL] [Abstract][Full Text] [Related]
4. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
[TBL] [Abstract][Full Text] [Related]
5. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
[TBL] [Abstract][Full Text] [Related]
6. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
Meerdink DJ; Leppo JA
Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
[TBL] [Abstract][Full Text] [Related]
7. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
Beller GA; Watson DD
Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
Johnson LL; Seldin DW
Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
10. A review of cardiac imaging with sestamibi and teboroxime.
Leppo JA; DePuey EG; Johnson LL
J Nucl Med; 1991 Oct; 32(10):2012-22. PubMed ID: 1833519
[TBL] [Abstract][Full Text] [Related]
11. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging.
Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA
J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447
[TBL] [Abstract][Full Text] [Related]
12. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Caner B; Beller GA
Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
[TBL] [Abstract][Full Text] [Related]
13. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
[TBL] [Abstract][Full Text] [Related]
14. The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study. Canadian Exercise Teboroxime SPECT Study Investigators.
Burns RJ; Iles S; Fung AY; Wright LM; Daigneault L
J Nucl Cardiol; 1995; 2(2 Pt 1):117-25. PubMed ID: 9420776
[TBL] [Abstract][Full Text] [Related]
15. Myocardial perfusion imaging using single-photon emission computed tomography.
Garvin AA; Cullom SJ; Garcia EV
Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
[TBL] [Abstract][Full Text] [Related]
16. Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model.
Di Bella EV; Ross SG; Kadrmas DJ; Khare HS; Christian PE; McJames S; Gullberg AG
Invest Radiol; 2001 Mar; 36(3):178-85. PubMed ID: 11228582
[TBL] [Abstract][Full Text] [Related]
17. Technetium 99m sestamibi in the assessment of chronic coronary artery disease.
Berman DS; Kiat H; Van Train K; Garcia E; Friedman J; Maddahi J
Semin Nucl Med; 1991 Jul; 21(3):190-212. PubMed ID: 1835137
[TBL] [Abstract][Full Text] [Related]
18. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
[TBL] [Abstract][Full Text] [Related]
19. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
